Click here to Login |
Contact us |
User Guide |
Home
English
|
Français
Search
Getting Started
Combine Queries
Data Basket Empty
Data by theme
Popular queries
Reset
Choose Theme
All Themes
General Statistics
Agriculture and Fisheries
Demography and Population
Development
Economic Projections
Education and Training
Environment
Finance
Globalisation
Health
Industry and Services
Information and Communication Technology
International Trade and Balance of Payments
Labour
National Accounts
Monthly Economic Indicators
Productivity
Prices and Purchasing Power Parities
Public Sector, Taxation and Market Regulation
Regions and Cities
Science, Technology and Patents
Social Protection and Well-being
Transport
Health
COVID-19 Health Indicators
Mortality (by week)
Mortality by week
Excess deaths by week, 2020-2023
COVID deaths by week, 2020-2023
Health expenditure and financing
Health expenditure and financing
Revenues of health care financing schemes
Input costs for health care providers
Gross fixed capital formation in the health care system
Expenditure by disease, age and gender under the System of Health Accounts (SHA) Framework
Current health spending by disease (ICD)
Inpatient/Hospital spending by disease (ICD)
Outpatient/ambulatory spending by disease (ICD)
Medical goods spending by disease (ICD)
Current health spending by age
Health Status
Health Status - Key Indicators
Mortality
Life expectancy
Causes of mortality
Maternal and infant mortality
Potential years of life lost
Avoidable mortality
Morbidity
Perceived health status
Perceived health status by age and gender
Perceived health status by socio-economic status
Infant health: low birthweight
Communicable diseases
Cancer
Injuries
Absence from work due to illness
Non-Medical Determinants of Health
Non-Medical Determinants of Health - Key Indicators
Tobacco consumption
Use of vaping products
Alcohol consumption
Food supply and consumption
Body weight
Health Care Resources
Health Care Resources
Total health and social employment
Physicians
Physicians by age and gender
Physicians by categories
Midwives
Nurses
Caring personnel (Personal care workers)
Dentists
Pharmacists
Physiotherapists
Hospital employment
Graduates
Remuneration of health professionals
Hospitals
Hospital beds by sector
Hospital beds by function of health care
Medical technology
Health Workforce Migration
Health Workforce Migration
Migration of doctors
Migration of nurses
Foreign-trained doctors by country of origin - Stock
Foreign-trained doctors by country of origin - Annual inflow
Foreign-trained nurses by country of origin - Stock
Foreign-trained nurses by country of origin - Annual inflow
Health Care Utilisation
Health Care Utilisation - Key Indicators
Consultations
Immunisation
Screening
Hospital aggregates
Hospital discharges by diagnostic categories
Hospital average length of stay by diagnostic categories
Diagnostic exams
Surgical procedures
Waiting times
Health Care Quality Indicators
Health Care Quality Indicators
Cancer Care
Mental Health Care
Patient Experiences
Patient Safety
Prescribing in primary care
Primary Care
Acute Care
Pharmaceutical Market
Pharmaceutical Market - Key Indicators
Pharmaceutical consumption
Pharmaceutical sales
Generic market
Long-Term Care Resources and Utilisation
Long-Term Care Resources and Utilisation - Key Indicators
Long-term care workers: formal sector
Formal long-term care workers at home
Formal long-term care workers in institutions
Beds in residential long-term care facilities
Long-term care recipients
Social Protection
Social Protection - Key Indicators
Total public and primary voluntary health insurance
Government/compulsory health insurance
Voluntary health insurance
Demographic References
Demographic References - Key Indicators
General demographics
Population age structure
Labour force: total civilian employment
Economic References
Economic References - Key Indicators
Macro-economic references
Monetary conversion rates
TiVA 2021: Principal Indicators
Economic Outlook
Gross domestic product (annual)
Gross domestic product (quarterly)
Composite Leading Indicators
Consumer price indices - inflation
Health Status
Labour Market Statistics
Monthly Monetary and Financial Statistics (MEI)
Agricultural Outlook
Bilateral Trade by Industry and End-use (ISIC4)
Statistics from A to Z
>> Data by theme
This dataset preview is momentarily unavailable.
Please try again or select another dataset.
Pharmaceutical Market
Customise
Selection…
Variable [65 / 65]
Measure [9 / 9]
Country [48 / 48]
Year [12]
Layout
Table options
Export
Excel
Text file (CSV)
PC-axis
SDMX (XML)
Related files
My Queries
Save
Combine
Manage
Variable
Total pharmaceutical consumption
A-Alimentary tract and metabolism
A02A-Antacids
A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)
A10-Drugs used in diabetes
B-Blood and blood forming organs
C-Cardiovascular system
C01A-Cardiac glycosides
C01B-Antiarrhythmics, Class I and III
C02-Antihypertensives
C03-Diuretics
C07-Beta blocking agents
C08-Calcium channel blockers
C09-Agents acting on the Renin-Angiotensin system
C10-Lipid modifying agents
G-Genito urinary system and sex hormones
G03-Sex hormones and modulators of the genital system
H-Systemic hormonal preparations, excluding sex hormones and insulins
J-Antiinfectives for systemic use
J01-Antibacterials for systemic use
M-Musculo-skeletal system
M01A-Antiinflammatory and antirheumatic products non-steroids
N-Nervous system
N02-Analgesics
N05B-Anxiolytics
N05C-Hypnotics and sedatives
N06A-Antidepressants
R-Respiratory system
R03-Drugs for obstructive airway diseases
Total pharmaceutical sales
Total pharmaceutical sales
A-Alimentary tract and metabolism
A02A-Antacids
A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)
A10-Drugs used in diabetes
B-Blood and blood forming organs
C-Cardiovascular system
C01A-Cardiac glycosides
C01B-Antiarrhythmics, Class I and III
C02-Antihypertensives
C03-Diuretics
C07-Beta blocking agents
C08-Calcium channel blockers
C09-Agents acting on the Renin-Angiotensin system
C10-Lipid modifying agents
G-Genito urinary system and sex hormones
G03-Sex hormones and modulators of the genital system
H-Systemic hormonal preparations, excluding sex hormones and insulins
J-Antiinfectives for systemic use
J01-Antibacterials for systemic use
M-Musculo-skeletal system
M01A-Antiinflammatory and antirheumatic products non-steroids
N-Nervous system
N02-Analgesics
N05B-Anxiolytics
N05C-Hypnotics and sedatives
N06A-Antidepressants
R-Respiratory system
R03-Drugs for obstructive airway diseases
Products not elsewhere classified
Generic market
Total pharmaceutical market
Third-party-payer market
Community pharmacy market
Hospital pharmaceutical market
Year
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
Measure
Country
Defined daily dosage per 1 000 inhabitants per day
Australia
(
D
)
80.4
(
D
)
88.9
(
D
)
91.7
(
B
D
)
96.2
(
D
)
100.7
(
D
)
104.1
(
D
)
106.5
(
D
)
109.3
(
D
)
112.2
(
D
)
115.6
122.2
..
Austria
(
D
)
54.2
(
D
)
57
(
D
)
58
(
D
)
59.3
(
D
)
60.3
(
D
)
60.3
(
D
)
60.5
(
D
)
61
(
D
)
61.3
(
D
)
62
(
D
)
63.2
..
Belgium
(
D
)
68.7
(
D
)
70
(
D
)
70.4
(
D
)
72.1
(
D
)
74.9
(
D
)
77.5
(
D
)
79
(
D
)
78.8
(
D
)
79.7
(
D
)
81.9
(
D
)
83.8
..
Canada
(
D
)
78.8
(
D
)
82.7
(
D
)
83.7
(
D
)
85
(
D
)
87.4
(
D
)
90.1
(
B
D
)
100.1
(
D
)
104.4
(
D
)
108.4
(
D
)
114.1
(
D
)
122
(
D
P
)
130.4
Chile
..
25.2
42.7
41.8
43.4
46.5
36.9
42
40.1
52
67
90.7
Costa Rica
21.9
24.4
26.1
29.7
29.9
28.4
29.3
30.9
33.4
35.9
39
..
Czech Republic
41.6
44.1
46.2
49
52.7
55
57.1
59.9
61.4
64.4
65.7
..
Denmark
84
85.2
83.2
80
76.6
77
76.4
75.7
76.6
78.3
80.7
84.6
Estonia
15.9
17.9
20.1
21.4
23.3
24.8
27.2
28.8
31.9
34.8
37
40.7
Finland
69.2
70.2
69.8
69.4
68.9
68.3
67.7
70.5
74.9
78.3
81.5
..
France
(
B
)
53.4
51.7
52
51.8
51.8
51.6
51.7
51.3
51.5
54.4
54.5
..
Germany
(
D
)
46.7
(
D
)
50
(
D
)
51.9
(
D
)
53.1
(
D
)
55.1
(
D
)
56.4
(
D
)
56.5
(
D
)
56.9
(
B
D
)
58.5
(
D
)
60.3
(
D
)
62.2
..
Greece
..
..
..
(
B
D
)
44.7
(
D
)
44.6
(
D
)
48.1
..
(
D
)
55.1
(
D
)
58
(
D
)
61
(
D
)
65.8
(
D
)
70.6
Hungary
(
D
)
26.4
(
D
)
27.3
(
D
)
26.8
(
D
)
27.5
(
D
)
27.7
(
D
)
28.3
(
D
)
28.4
(
D
)
28.8
(
D
)
29.3
(
D
)
29.5
(
D
)
30.4
(
D
)
29.8
Iceland
101.3
(
B
D
)
103.8
(
D
)
106.3
(
D
)
113.7
(
D
)
115.7
(
D
)
125.8
(
D
)
133
(
D
)
138.6
(
D
)
142
(
D
)
146
(
D
)
153.4
(
D
)
161.1
Israel
..
..
(
D
)
34.3
..
(
D
)
42.1
(
D
)
44.4
(
D
)
46.7
(
D
)
49.2
(
D
)
51.1
(
D
)
53.8
(
D
)
55.4
(
D
)
57.7
Italy
..
38.4
38.6
39.1
39.3
39.6
39.9
40.4
41.6
42.4
43.7
(
E
)
44.4
Korea
11.3
(
B
)
13.8
15.2
17
18
20.3
(
B
)
17.2
18.8
21
23.4
27.4
..
Latvia
..
..
9.5
10.2
11.1
12.3
13.3
15
16.1
17.6
19.8
21.5
Lithuania
19.2
20.8
23.4
24.7
25.7
27.9
29.3
32.1
31.3
35.4
36.8
..
Luxembourg
(
D
)
50.1
(
D
)
51.4
(
D
)
52
(
D
)
53.4
(
D
)
56
(
D
)
53.7
(
D
)
54.2
(
D
)
53
(
D
)
52.9
(
D
)
54.9
(
D
P
)
55.3
(
B
D
P
)
57.3
Netherlands
(
D
)
40.4
(
D
)
41.6
(
D
)
42.4
(
D
)
43.3
(
D
)
44.3
(
D
)
45.5
(
D
)
45.9
(
D
)
46.2
(
D
)
47.2
(
D
)
47.9
(
D
)
47.3
..
New Zealand
..
..
..
..
(
D
)
72.8
..
..
..
..
..
..
..
Norway
56.5
57.7
57.5
56.9
57.1
58
57.6
57.3
56.2
57.9
58.7
61.1
Portugal
(
D
)
78.7
(
D
)
78.3
(
D
)
84.5
(
D
)
87.5
(
D
)
92.1
(
D
)
95.1
(
D
)
99.5
(
D
)
103.8
(
D
)
109.3
(
D
)
123.7
(
D
)
131
(
D
)
139.6
Slovak Republic
29
30.7
30.2
35.2
38.1
40
(
B
)
38.9
39.4
41.1
47.6
48.2
..
Slovenia
(
D
)
44.1
(
D
)
50
(
D
)
51
(
D
)
53.3
(
D
)
55
(
D
)
56.8
(
D
)
58.6
(
D
)
59.5
(
D
)
61.5
(
D
)
63.3
(
D
)
63.6
..
Spain
(
D
)
61.2
(
D
)
63.9
(
D
)
64
(
D
)
65.2
(
B
D
)
71.3
(
D
)
73.1
(
D
)
75.5
(
D
)
77.2
(
B
)
80.4
83.6
86.9
(
P
)
92
Sweden
75.8
79.4
81.1
84.3
87.8
92.5
95
96.9
98.7
102.7
105.4
108.9
Türkiye
(
D
)
32.7
(
D
)
37
(
D
)
37.3
(
D
)
36.3
(
D
)
38.1
(
D
)
40.7
(
D
)
41
(
D
)
43.5
(
D
)
44.1
(
D
)
44.2
(
D
)
48.9
..
United Kingdom
(
D
)
65.9
(
D
)
70.7
(
D
)
75
(
B
D
)
82.3
(
D
)
87.8
(
D
)
94.2
(
D
)
100.1
(
D
)
107.9
..
..
..
..
Legend:
B
Break
D
Difference in methodology
E
Estimated value
P
Provisional value
Data extracted on 26 Mar 2023 20:22 UTC (GMT) from
OECD.Stat
Loading...
Information
Please check the i to get information